Stock Report

All about this stock under one free report Last Updated: 23-May-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Anthem Biosciences Ltd

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: ANTHEM | BSE: 544449

₹777.10

up-down-arrow ₹8.00 (1.04%)

As on 22-May-2026IST

Market cap

info icon

₹43,735 Cr

Revenue (TTM)

info icon

₹2,124 Cr

P/E Ratio

info icon

73.9

P/B Ratio

info icon

14.4

Div. Yield

info icon

0 %

Value Research Rating

Quality Score fund-quick-summary-circle

Quality Score9/10

Growth Score fund-quick-summary-circle

Growth Score7/10

Valuation Score fund-quick-summary-circle

Valuation Score4/10

Momentum Score fund-quick-summary-circle

Momentum Score10/10

Know more link icon Explore 5 star rated stocks link icon

Anthem Biosciences Share Price

Compare

High:loading Low:loading Return: loading

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Price P/E Ratio P/B Ratio
loading...
loading...
NSEBSE
loading...
loading...
loading...
loading...
NSEBSE
loading...
loading...

Stock Range

Today’s Range

Low: 771.35 High: 783.85

52 Week Range

Low: 579.15 High: 873.50

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹592 Cr

  • ROEROE information

    21 %

  • ROCEROCE information

    28.5 %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    44

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    ₹54

  • EPSEPS information

    ₹10.8

  • Face valueFace value information

    2

  • Shares outstandingShares outstanding information

    563,195,101

10 Years Aggregate

CFO

₹759.16 Cr

EBITDA

₹3,250.30 Cr

Net Profit

₹2,202.40 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Anthem Biosciences
19.3 5.3 14.0 -- -- -- --
BSE Healthcare
8.8 8.8 9.7 11.0 27.5 14.1 12.0
As on 22-May-2026
The underlying data is unavailable.

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...
Quarterly Annual

*All values are in (₹ Cr)

loading...
Annual

*All values are in (₹ Cr)

loading...
Annual

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
 Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Anthem Biosciences
777.1 43,734.9 2,124.3 591.8 32.9 21 73.9 14.4
Apollo Hospitals
8,362.5 1,20,200.4 25,228.5 1,957.7 11.5 21.1 61.9 12.7
Aster Dm Health
756.6 39,185.5 4,643.2 464.1 13.7 8.9 101 8.6
Dr. Lal Pathlabs
1,630.1 27,275.5 2,762.9 509.8 22.5 21.5 54 10.9
Fortis Healthcare
960.4 72,510.0 9,127.8 1,047.8 17.9 11 69.6 7.3
Global Health
1,238.1 33,297.3 4,410.2 554.1 15.8 14.5 59.8 8.4
Krishna Institute
764.1 30,572.6 3,904.6 239.4 13.3 11.1 126.6 13.6
Max Healthcare
1,023.3 99,587.2 8,373.5 1,442.4 21.5 14.3 69 9.3
Narayana Hrud
1,855.6 37,895.7 7,896.0 811.6 14.8 19.8 47 9.0
Vimta Labs
451.6 2,016.8 407.3 77.5 24.0 18 26 4.4

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News
Anthem Biosciences IPO analysis

Anthem Biosciences IPO analysis

5 min read•By  Abhinav Goel

About Anthem Biosciences

--

  • Incorporated

    2006

  • Chairman

    Ajay Bhardwaj

  • Managing Director

    Ajay Bhardwaj

  • Headquarters

    Bengaluru, Karnataka

  • Website

    www.anthembio.com

Looking for more details about Anthem Biosciences Ltd’s IPO? Explore our IPO Details page.

Value Research Ratings

Our rating system has guided millions of investors in the past 20 years.

Top Rated Stocks

All stocks with 5-star Value Research Ratings

Top Rated Stocks Icon

High Quality Small Caps

Small-cap stocks rated high on quality score

High Quality Small Caps Icon

High Growth Large Caps

Large-cap stocks with a high growth score

High Growth Large Caps Icon

Value Meets Momentum

Top momentum stocks with a high valuation score

Value Meets Momentum Icon

Top Rated Banks

Banks that rate high on Value Research Stock Ratings

Top Rated Banks Icon
Explore Screeners
Edit peer-selector-edit

FAQs for Anthem Biosciences

The share price of Anthem Biosciences Ltd is ₹777.10 (NSE) and ₹776.55 (BSE) as of 22-May-2026 IST. Anthem Biosciences Ltd has given a return of --% in the last 1 years.

The P/E ratio of Anthem Biosciences Ltd is 73.90 times as on 22-May-2026.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
0.00
0.00
2024
0.00
0.00
2023
0.00
0.00
2022
0.00
0.00
2021
0.00
0.00

The 52-week high and low of Anthem Biosciences Ltd are Rs 873.50 and Rs 579.15 as of 23-May-2026.

Anthem Biosciences Ltd has a market capitalisation of ₹ 43,735 Cr as on 22-May-2026. As per SEBI classification, it is a Mid Cap company.

Before investing in Anthem Biosciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.